|
PSMA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.373000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.975200E-01 |
| Normal-vs-Stage2 |
9.030800E-01 |
| Normal-vs-Stage3 |
1.225640E-01 |
| Normal-vs-Stage4 |
2.055200E-01 |
| Stage1-vs-Stage2 |
8.192000E-01 |
| Stage1-vs-Stage3 |
6.658300E-02 |
| Stage1-vs-Stage4 |
8.681500E-02 |
| Stage2-vs-Stage3 |
1.303010E-01 |
| Stage2-vs-Stage4 |
1.488780E-01 |
| Stage3-vs-Stage4 |
9.742600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.938800E-01 |
| Normal-vs-AfricanAmerican |
5.557400E-01 |
| Normal-vs-Asian |
9.056300E-02 |
| Caucasian-vs-AfricanAmerican |
1.800200E-01 |
| Caucasian-vs-Asian |
7.484000E-02 |
| AfricanAmerican-vs-Asian |
1.084430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.672000E-01 |
| Normal-vs-Female |
3.296600E-01 |
| Male-vs-Female |
6.881600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.584000E-01 |
| Normal-vs-Extreme_Weight |
9.905800E-01 |
| Normal-vs-Obese |
5.849800E-01 |
| Normal-vs-Extreme_Obese |
3.859400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.497000E-01 |
| Normal_Weight-vs-Obese |
4.976000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.163400E-01 |
| Extreme_Weight-vs-Obese |
5.874400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.819200E-01 |
| Obese-vs-Extreme_Obese |
6.351800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.994200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.515400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.302400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.979200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.492100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.946350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.418000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.880150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.441800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.671800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.546600E-01 |
| Normal-VS-Type2 PRCC |
6.334200E-01 |
| Normal-VS-KIRP CIMP |
1.652400E-02 |
| Normal-VS-Unclassified PRCC |
7.554100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.136200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.352080E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.926400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.979200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.524600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.123900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.826600E-01 |
| Normal-vs-N1 |
1.941750E-03 |
| Normal-vs-N2 |
5.363000E-03 |
| N0-vs-N1 |
3.432900E-04 |
| N0-vs-N2 |
6.725500E-02 |
| N1-vs-N2 |
7.403800E-03 |
|
|
